MIR21
MIR21 encodes microRNA-21 (miR-21), a small non-coding RNA that functions as a post-transcriptional regulator of gene expression.
MIR21 encodes microRNA-21 (miR-21), a small non-coding RNA that functions as a post-transcriptional regulator of gene expression. Like other microRNAs, it acts by binding target messenger RNAs and modulating their stability or translation, thereby influencing cellular programs such as proliferation, apoptosis, and stress responses. In biomedical research, miR-21 is widely studied as a cancer-associated biomarker and regulatory molecule, particularly in breast cancer and other solid tumors.
Recent studies have continued to use MIR21 as a model target for both mechanistic cancer research and ultrasensitive molecular detection. In these contexts, miR-21 is frequently discussed alongside breast cancer, triple-negative breast adenocarcinoma, colorectal, head/neck, melanoma, and prostate tumors, reflecting its broad relevance in oncology. It has also been investigated in relation to pathways and molecular factors such as PTEN and the SIRT1/HIF-1α pathway, consistent with its role in tumor biology and treatment response.
Where the papers sit
14 papers from the last 6 months study MIR21 directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 12 human data · 2 preclinical
Themes 3 themes · 1 new direction
-
miRNA Cancer Detection
Ultrasensitive miRNA detection is moving toward multiplex, amplification-assisted CRISPR and nanomaterial biosensors for cancer screening and monitoring. Cas12a, CRISPR editing, G-quadruplexes, nanozymes, DNA walkers and catalytic hairpin circuits recur, with bladder cancer a frequent application. Platforms target low detection limits in urine or other clinical samples and increasingly seek label-free, colorimetric or portable readouts. The biological effect of miR-21 editing is represented, but the cluster mainly addresses analytical detection rather than treatment.
9 papers · 64.3%
-
Multiplex Cancer miRNA Detection
Cancer miRNA testing is moving toward rapid, multiplex visual assays that combine logic gating with nanoparticle signal generation. Gold nanoparticles, DNA self-assembly and AND gates are used to require concurrent biomarkers, including MIR155 and miR-21, to improve diagnostic specificity. Breast cancer and hepatocellular carcinoma provide the main application contexts, with colorimetric and lateral-flow formats favoring accessible readouts. The work remains at assay-development stage, so clinical discrimination and prospective validation are unresolved.
3 papers · 21.4%
-
Intracellular miRNA Imaging
Intracellular miRNA imaging is being refined toward higher specificity and lower background rather than bulk measurement. Cas13a and DNA circuits use dual-key or endogenous APE1 activation to constrain fluorescence to miRNA-positive living cells. Free-amplified or autocatalytic signal generation aims to improve signal-to-noise and spatial precision. The small set supports proof-of-concept imaging, while clinical validation and quantitative performance in tissue remain open.
2 papers · 14.3%
miR-21 is treated as an editable causal target in urothelial carcinoma rather than merely as a detectable biomarker or drug-responsive pathway component
CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells 42319574Jun moves miR-21 beyond the set's usual roles as a cancer-associated analyte in diagnostic assays or as an expression change associated with pharmacologic treatment. By directly editing miR-21 and examining the resulting biological effects, the study treats it as a manipulable causal target in tumor cells, opening a gene-editing direction rather than another application of biomarker detection or pathway modulation.
Papers
The 14 papers from the last 6 months that study MIR21 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
miRNA Cancer Detection (9)
- A cascaded signal amplification strategy combining Au@Cu2O core-shell nanozymes and CRISPR-Cas12a self-cycling for ultrasensitive colorimetric detection of miRNA-21. Analytica chimica acta · 6 Sept 2026 PMID 42702425
- A Dual-Mode Fluorescent and Colorimetric Biosensor Based on AuNPs@RCA Nanogel-Integrated Multipedal DNA Walker for Ultrasensitive miRNA Detection. ACS applied materials & interfaces · 2 Sept 2026 PMID 42682078
- A hydrogel microsphere-based catalytic hairpin assembly for simple miRNA detection. Analytical methods : advancing methods and applications · 1 Sept 2026 PMID 42676189
- Nucleic acid probe-functionalized self-powered sensor for detection of biomarkers in clinical urine samples. Science advances · 5 Aug 2026 PMID 42555722
- Topology-Gated λ Exonuclease Enables Amplification-Free Signal Boosting. Journal of the American Chemical Society · 21 Jul 2026 PMID 42479891
- Compartmentalization-inspired dual-chamber CRISPR sensing coupled with single-atom electrocatalysis for crosstalk-free multiplex microRNA detection. Biosensors & bioelectronics · 9 Jul 2026 PMID 42424999
- Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical chemistry · 9 Jul 2026 PMID 42424186
- CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. Molecular biology reports · 19 Jun 2026 PMID 42319574
- Dual MicroRNA Simultaneous One-Step Profiling via Filler-Mediated Quantum Dot DNA Nanospheres for Bladder Cancer Screening. ACS nano · 13 Jun 2026 PMID 42287261
Multiplex Cancer miRNA Detection (3)
- A lateral flow assay strip based on AND logic gate and DNA self-assembly for dual miRNA detection in breast cancer diagnosis. Mikrochimica acta · 4 Aug 2026 PMID 42550284
- Modular CRISPR-Cas12a-Activated Gold Nanoparticle Assay for Rapid Visual Detection of Hepatocellular Carcinoma-Related miRNAs. ACS sensors · 9 Jun 2026 PMID 42263201
- Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme. Analytica chimica acta · 1 Jun 2026 PMID 42219637
Intracellular miRNA Imaging (2)
- A double-key responsive TDNs-HC/Cas13a DNA circuit for free-amplified detection and precise imaging of miRNAs in living cell. Analytica chimica acta · 19 Sept 2026 PMID 42763165
- Autocatalytic DNA nanosphere assembly activated by endogenous APE1 for intracellular miR-21 imaging. Analytica chimica acta · 7 Aug 2026 PMID 42567595
By study type
Human data, design not indexed (12)
- A double-key responsive TDNs-HC/Cas13a DNA circuit for free-amplified detection and precise imaging of miRNAs in living cell. Analytica chimica acta · 19 Sept 2026 PMID 42763165
- A cascaded signal amplification strategy combining Au@Cu2O core-shell nanozymes and CRISPR-Cas12a self-cycling for ultrasensitive colorimetric detection of miRNA-21. Analytica chimica acta · 6 Sept 2026 PMID 42702425
- A Dual-Mode Fluorescent and Colorimetric Biosensor Based on AuNPs@RCA Nanogel-Integrated Multipedal DNA Walker for Ultrasensitive miRNA Detection. ACS applied materials & interfaces · 2 Sept 2026 PMID 42682078
- A hydrogel microsphere-based catalytic hairpin assembly for simple miRNA detection. Analytical methods : advancing methods and applications · 1 Sept 2026 PMID 42676189
- Autocatalytic DNA nanosphere assembly activated by endogenous APE1 for intracellular miR-21 imaging. Analytica chimica acta · 7 Aug 2026 PMID 42567595
- Nucleic acid probe-functionalized self-powered sensor for detection of biomarkers in clinical urine samples. Science advances · 5 Aug 2026 PMID 42555722
- A lateral flow assay strip based on AND logic gate and DNA self-assembly for dual miRNA detection in breast cancer diagnosis. Mikrochimica acta · 4 Aug 2026 PMID 42550284
- Topology-Gated λ Exonuclease Enables Amplification-Free Signal Boosting. Journal of the American Chemical Society · 21 Jul 2026 PMID 42479891
- Compartmentalization-inspired dual-chamber CRISPR sensing coupled with single-atom electrocatalysis for crosstalk-free multiplex microRNA detection. Biosensors & bioelectronics · 9 Jul 2026 PMID 42424999
- Dual MicroRNA Simultaneous One-Step Profiling via Filler-Mediated Quantum Dot DNA Nanospheres for Bladder Cancer Screening. ACS nano · 13 Jun 2026 PMID 42287261
- Modular CRISPR-Cas12a-Activated Gold Nanoparticle Assay for Rapid Visual Detection of Hepatocellular Carcinoma-Related miRNAs. ACS sensors · 9 Jun 2026 PMID 42263201
- Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme. Analytica chimica acta · 1 Jun 2026 PMID 42219637
Preclinical: animal, cell and lab studies (2)
- Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical chemistry · 9 Jul 2026 PMID 42424186
- CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. Molecular biology reports · 19 Jun 2026 PMID 42319574
Written from 14 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.